NCI Funding in USA for Nanotechnology in Cancer (30’ Speech and 10’ Questions)
The US National Cancer Institute (NCI) established the Alliance for Nanotechnology in Cancer in 2005 to recognize the value of convergence between nanotechnology and cancer research. It was the first program to support large-scale cooperative research in this area of medicine. The past fourteen years of the program’s operation resulted in the publication of more than 4,000 peer reviewed research articles, formation of several start-up companies collaborating with NCI-funded academic centers and committed to translation and commercialization of nanotechnology-based interventions, and over 20 clinical trials associated with these interventions. The talk will provide the update on the program activities and outline its new strategic directions.
Chair Prof. Dr. med. Patrick Hunziker, President of the International Society for Nanomedicine, Basel (CH
Update of the Alliance of the National Cancer Institute for Nanotechnology in Cancer
Dr. Piotr Grodzinski, Director, NCI Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, Maryland (USA)
12.00 Questions and debate
